Autolus Therapeutics plc
Commercial-stage programmed T-cell company led by AUCATZYL, with expansion into pediatric oncology and autoimmune disease.
Hematologic malignancies & autoimmune disease · Programmed autologous CAR-T cell therapy · Commercial + Phase 2